ID   CAV2_HORSE              Reviewed;         162 AA.
AC   Q2QLB1;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   07-APR-2021, entry version 75.
DE   RecName: Full=Caveolin-2;
GN   Name=CAV2;
OS   Equus caballus (Horse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
OX   NCBI_TaxID=9796;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Antonellis A., Ayele K., Benjamin B., Blakesley R.W., Boakye A.,
RA   Bouffard G.G., Brinkley C., Brooks S., Chu G., Coleman H., Engle J.,
RA   Gestole M., Greene A., Guan X., Gupta J., Haghighi P., Han J., Hansen N.,
RA   Ho S.-L., Hu P., Hunter G., Hurle B., Idol J.R., Kwong P., Laric P.,
RA   Larson S., Lee-Lin S.-Q., Legaspi R., Madden M., Maduro Q.L., Maduro V.B.,
RA   Margulies E.H., Masiello C., Maskeri B., McDowell J., Mojidi H.A.,
RA   Mullikin J.C., Oestreicher J.S., Park M., Portnoy M.E., Prasad A., Puri O.,
RA   Reddix-Dugue N., Schandler K., Schueler M.G., Sison C., Stantripop S.,
RA   Stephen E., Taye A., Thomas J.W., Thomas P.J., Tsipouri V., Ung L.,
RA   Vogt J.L., Wetherby K.D., Young A., Green E.D.;
RT   "NISC comparative sequencing initiative.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May act as a scaffolding protein within caveolar membranes.
CC       Interacts directly with G-protein alpha subunits and can functionally
CC       regulate their activity. Acts as an accessory protein in conjunction
CC       with CAV1 in targeting to lipid rafts and driving caveolae formation.
CC       Positive regulator of cellular mitogenesis of the MAPK signaling
CC       pathway. Required for the insulin-stimulated nuclear translocation and
CC       activation of MAPK1 and STAT3, and the subsequent regulation of cell
CC       cycle progression (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer or homodimer (By similarity). Interacts with CAV1; the
CC       interaction forms a stable heterooligomeric complex that is required
CC       for targeting to lipid rafts and for caveolae formation. Tyrosine
CC       phosphorylated forms do not form heterooligomers with the Tyr-19-
CC       phosphorylated form existing as a monomer or dimer, and the Tyr-27-form
CC       as a monomer only. Interacts (tyrosine phosphorylated form) with the
CC       SH2 domain-containing proteins, RASA1, NCK1 and SRC. Interacts
CC       (tyrosine phosphorylated form) with INSR, the interaction (Tyr-27-
CC       phosphorylated form) is increased on insulin stimulation. Interacts
CC       (Tyr-19 phosphorylated form) with MAPK1 (phosphorylated form); the
CC       interaction, promoted by insulin, leads to nuclear location and MAPK1
CC       activation. Interacts with STAT3; the interaction is increased on
CC       insulin-induced tyrosine phosphorylation leading to STAT activation (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.
CC       Golgi apparatus membrane; Peripheral membrane protein. Cell membrane;
CC       Peripheral membrane protein. Membrane, caveola; Peripheral membrane
CC       protein. Note=Potential hairpin-like structure in the membrane.
CC       Membrane protein of caveolae. Tyr-19-phosphorylated form is enriched at
CC       sites of cell-cell contact and is translocated to the nucleus in
CC       complex with MAPK1 in response to insulin. Tyr-27-phosphorylated form
CC       is located both in the cytoplasm and plasma membrane. CAV1-mediated
CC       Ser-23-phosphorylated form locates to the plasma membrane (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on serine and tyrosine residues. CAV1 promotes
CC       phosphorylation on Ser-23 which then targets the complex to the plasma
CC       membrane, lipid rafts and caveolae. Phosphorylation on both Tyr-19 and
CC       Tyr-27 is required for insulin-induced 'Ser-727' phosphorylation of
CC       STAT3 and its activation. Phosphorylation on Tyr-19 is required for
CC       insulin-induced phosphorylation of MAPK1 and DNA binding of STAT3.
CC       Tyrosine phosphorylation is induced by both EGF and insulin (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the caveolin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DP000020; ABB89798.1; -; Genomic_DNA.
DR   RefSeq; NP_001107616.1; NM_001114144.1.
DR   SMR; Q2QLB1; -.
DR   PaxDb; Q2QLB1; -.
DR   PRIDE; Q2QLB1; -.
DR   GeneID; 100071136; -.
DR   KEGG; ecb:100071136; -.
DR   CTD; 858; -.
DR   InParanoid; Q2QLB1; -.
DR   OMA; CLHIWVV; -.
DR   OrthoDB; 1468974at2759; -.
DR   Proteomes; UP000002281; Unplaced.
DR   GO; GO:0005901; C:caveola; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IBA:GO_Central.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IBA:GO_Central.
DR   GO; GO:0070836; P:caveola assembly; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; ISS:UniProtKB.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0060161; P:positive regulation of dopamine receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB.
DR   GO; GO:0048278; P:vesicle docking; ISS:UniProtKB.
DR   GO; GO:0006906; P:vesicle fusion; ISS:UniProtKB.
DR   InterPro; IPR033306; CAV-2.
DR   InterPro; IPR001612; Caveolin.
DR   InterPro; IPR018361; Caveolin_CS.
DR   PANTHER; PTHR10844; PTHR10844; 1.
DR   PANTHER; PTHR10844:SF3; PTHR10844:SF3; 1.
DR   Pfam; PF01146; Caveolin; 1.
DR   PROSITE; PS01210; CAVEOLIN; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Cytoplasm; Golgi apparatus; Membrane; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..162
FT                   /note="Caveolin-2"
FT                   /id="PRO_0000226340"
FT   TOPO_DOM        1..86
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        87..107
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        108..162
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         19
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P51636"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVC3"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51636"
FT   MOD_RES         27
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P51636"
SQ   SEQUENCE   162 AA;  18094 MW;  1388FC382E933391 CRC64;
     MGLETEKADV QLFLDDESYS RHSGVDYADP EKFADAGLDR DPHRLNSHLK VGFEDVIAEP
     VSTHSFDKVW ICSHALFEIS KYVIYKFLTV FLAIPLAFVA GILFATLSCL HIWIIMPFVK
     TCLMLLPSVQ TIWKSVTDVV IAPLCTSAGR SFSSVSLQLS HD
//
